Dana Aftab Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Dana Aftab has an estimated net worth of at least $37.3 million*, as of Oct. 29, 2025. They own 668,124 shares of EXEL stock. They have sold 455,800 shares of EXEL stock since 2021, for an estimated $9.0 million.
Dana Aftab $EXEL SEC Form 4 Insider Trading
Dana Aftab has filed a total of 12 insider trades in $EXEL since 2021. Their most recent trade was a sale of 47,918 shares, made on Feb 24, 2026. Their largest trade was a sale of 96,986 shares, made on Nov 05, 2024. We estimate that they now own 668,124 shares of $EXEL, worth an estimated $28.3 million.
Insider Trading at $EXEL
There have been a total of 130 insider trades reported at $EXEL since 2021, with 762,941 shares purchased and 4.1 million shares sold. The most active insider traders in $EXEL stock have been Patrick J. Haley, Jeffrey Hessekiel, and Dana Aftab. The most recent trade was a sale of 47,918 shares reported by Dana Aftab (EVP, Research and Development), made on Feb 24, 2026.
History of Insider Stock Trades by Dana Aftab
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
EXEL
|
Sale | 47,918 | Feb 24, 2026 | Feb. 26, 2026, 9:59 p.m. |
|
EXEL
|
Sale | 29,873 | Feb 19, 2026 | Feb. 23, 2026, 7:50 p.m. |
|
EXEL
|
Sale | 48,383 | Nov 11, 2025 | Nov. 13, 2025, 8:12 p.m. |
|
EXEL
|
Sale | 1,508 | May 01, 2025 | May 5, 2025, 7:12 p.m. |
|
EXEL
|
Sale | 26,987 | Feb 24, 2025 | Feb. 26, 2025, 9 p.m. |
|
EXEL
|
Sale | 96,986 | Nov 05, 2024 | Nov. 7, 2024, 8:44 p.m. |
|
EXEL
|
Sale | 1,162 | Oct 30, 2024 | Nov. 1, 2024, 6:43 p.m. |
|
EXEL
|
Sale | 20,883 | Aug 12, 2024 | Aug. 14, 2024, 7:12 p.m. |
|
EXEL
|
Sale | 95,000 | Aug 07, 2024 | Aug. 9, 2024, 7:32 p.m. |
|
EXEL
|
Sale | 4,600 | Aug 30, 2023 | Sept. 1, 2023, 8:15 p.m. |
|
EXEL
|
Sale | 10 | Feb 27, 2023 | March 1, 2023, 8:56 p.m. |
|
EXEL
|
Sale | 82,490 | Feb 28, 2023 | March 1, 2023, 8:56 p.m. |
$EXEL Executives and Stock Owners with Insider Trades
-
Patrick J. Haley, EVP, Commercial
-
Jeffrey Hessekiel, EVP, General Counsel & Sec
-
Dana Aftab, CSO/EVP Disc & Trans Research
-
Peter Lamb, EVP, Scientific Strategy & CSO
-
Christopher J. Senner, EVP and CFO
-
Jeffrey Hessekiel, EVP & General Counsel
-
Dana Aftab, EVP, Research and Development
-
Jeffrey Hessekiel, EVP and General Counsel
-
Amy C. Peterson, EVP Prod Dev & Med Aff & CMO
-
Brenda Hefti, SVP and General Counsel
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.